ph3Overview /h3 pThis is a critical leadership position dedicated to driving market access, pricing strategy, and contracting for our best-in-class oncology and hematology therapies. In this high-impact role, you will spearhead US pricing and life-cycle strategies for key products, including Orserdu and Elzonris. Acting as the strategic and financial linchpin between brand, finance, and market access teams, you will lead the team responsible for executing complex deal analytics, optimizing gross-to-net (GTN) performance, and designing comprehensive contracting frameworks to remove access barriers across payors, Specialty Pharmacy Networks, and GPOs. Furthermore, you will champion operational excellence by leading a dedicated team to ensure 100% compliance with government pricing regulations—expertly navigating state transparency laws, 340B impacts, and Medicaid models to secure our market leadership in a high-scrutiny sector. /p h3Responsibilities /h3 pbResponsibilities /b /p h3Pricing Strategy, Financial Modeling Gross-to-Net (GTN) /h3 ul liSpearhead US pricing for Orserdu and life-cycle strategy for Elzonris, establishing value benchmarks and market leadership for best-in-class oncology and hematology therapies. /li liFormulate, model, and execute price changes for Orserdu and Elzonris, routing PI communications and compendia submissions through internal stakeholders. /li liManage quarterly and monthly GTN analyses and breakouts for leadership review. /li liLead the development of deal analytics and scenario models to assess profitability, rebate structures, and Gross-to-Net (GTN) impacts across all commercial channels. /li liCoordinate with brand and finance to deliver segment specific insight/modeling to help inform contract strategy development and impact.



/li liServes as a resource for Licensing and Business Development in assessing price for potential opportunities. /li /ul h3Payer Contracting, GPO Distribution Strategy /h3 ul liIn coordination with Market Access field teams, develops contracting and pricing strategies to ensure profitable uptake of the Stemline portfolio. /li liEstablish portfolio-level guardrails and decision frameworks to optimize access across payors, GPOs, specialty distributors, and large provider networks. /li liLead contracting strategy workshops with payor team, and GPO team to remove any access barriers for Orserdu. /li liDesigning Payer Contracting Deal Analytics models for Commercial and Medicare lines of business, sales forecasts by payer plan, and establishing standard MSA/Proposal templates. /li liWorks closely with Account teams to negotiate and implement contracting strategies and ensures implementation of contract strategies and contracting platforms. /li liIn coordination with the commercial trade and distribution team, develops and/or manages Specialty Pharmacy Networks strategy and performance based on aligned brand strategies. /li liWill work closely with Market Access field teams and Medical Affairs to develop and evaluate Value Based Arrangements. /li /ul h3Government Pricing, Programs State Transparency /h3 ul liManage a team ensuring 100% compliance with state drug price transparency regulations and government price reporting,



effectively mitigating audit risks in the high-scrutiny oncology sector. /li liLead 340B analysis of distribution changes, contracting initiatives, as well as new federal and state legislation. /li liOversee Orserdu and Elzonris Medicaid waterfall models. /li liResponsible for Federal Supply Schedule (FSS) contract renewals and contract adherence. /li liOversight of State Price Transparency Reporting including collaborating to maintain the state disclosure (e.g., CT, VT, and CO). /li liOversee the Pharmaceutical Product Stewardship Work Group program enrollment, tracking state forms, and ensuring timely invoice payments. /li liCoordinate with internal and external resources regarding operational activities such as rebates, chargebacks, government reporting, contract writing, and process approvals. /li /ul h3Government Affairs Policy Analytics /h3 ul liEvaluate the impact of governmental pricing proposals, policies, and regulations (e.g., Most Favored Nation). /li liSupport public policy strategy in partnership with Government Affairs by assisting with public comment periods and advocating for small manufacturers. /li liQuantify the financial implications of healthcare reform (e.g., Medicare Part D redesign, inflation rebates, MFN) on the pipeline to inform long-term pricing and contracting tradeoffs. /li /ul h3Market Intelligence Field Enablement /h3 ul liDeep understanding of payer environment (both medical and pharmacy agevolazioni), competitive market conditions that affect pricing for our oncology products and the pharmaceutical industry overall. /li liTranslate complex pricing, contracting, and policy landscape shifts into actionable intelligence and tactical materials for field teams. /li liEnsure field readiness for negotiations a

📌 Sr. Director, Contract Strategy, Pricing (Italia)
🏢 Menarini
📍 Italia